The most commonly reported side effects include nausea, constipation, diarrhea, vomiting, indigestion, and stomach pain
Boehringer Ingelheim's survodutide, a GLP-1/glucagon dual agonist without the GIP component, is a different shape of bet on the same hypothesis: that going beyond pure GLP-1 is where the next decade of obesity pharmacology lives
Image Credit: While of My Desk / Shutterstock In a recent study published in the journal Scientific Reports , a group of researchers evaluated whether maternal exposure to glucagon-like peptide-1 (GLP-1) receptor agonists during the periconceptional period or pregnancy is associated with congenital malformations or other adverse pregnancy outcomes
Because it might be going right well into the system, the body shall simply absorb it very efficiently
1 Safety The most common adverse effect of semaglutide is an increase in heart rate, with an increase of 10 to 19 beats per minute in 41% of patients (34% with placebo) and 20 beats per minute in 26% of patients (vs